Heavy metal analysis in the pharmaceutical industry

Industrialists in the pharmaceutical industry, you wish to carry out analysis of heavy metals

Why analyse heavy metals in the pharmaceutical industry?

Firstly, heavy metals are elemental impurities from the manufacturing processes of pharmaceutical substances. They originate from the reagents, ligands or catalysts used.

According to the European and American pharmacopoeias, for the safety of patients, heavy metals in finished pharmaceuticals and raw materials must not exceed given limit values and must therefore be analysed. 

Thus, the support of a competent laboratory for the analysis of heavy metals is indispensable in the context of controls and regulatory procedures for the marketing of pharmaceutical products.

FILAB supports you in your heavy metal analysis needs

Through our three levels of services: analysis, expertise and R&D support, FILAB assists pharmaceutical companies in the analysis of heavy metals. FILAB provides its clients with the know-how and experience of its team, as well as a 2100m² analytical park equipped with state-of-the-art equipment.

our services

  • ICP elemental impurity analysis according to USP 233 in pharmaceutical products (ICH Q3D regulatory compliance)

The positive aspects of FILAB

  • A highly qualified team

  • Responsiveness in responding to and processing requests

  • A complete analytical park of 2100m²

  • Tailor-made support

Clément BOENARD Head of Inorganic Chemistry Department
Ask for your quote
+33 (0)3 80 52 32 05 Request
a quote